Emerging role of serum biomarkers in neurodegenerative dementias in a diverse context

Faheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi · 2025

Read Emerging role of serum biomarkers in neurodegenerative dementias in a diverse context by Faheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714681.txt.

Description

Arshad and co-authors tested two blood markers for dementia diagnosis in India, in a study published in 2025. Dementias overlap in symptoms, so clinical judgment alone mislabels many patients. Brain scans and spinal taps are scarce outside rich centers. Two blood proteins offer a shortcut: one tracks brain inflammation, the other nerve fiber damage. Neither depends on the classic Alzheimer's proteins, so they might separate dementia types instead.

Ninety-nine participants received deep cognitive testing and basic brain imaging. The team compared marker levels between Alzheimer's patients, frontotemporal dementia patients, and controls. Validating the markers in a diverse, lower-resource population is the point: most evidence comes from Western cohorts. A cheap blood test that travels well could transform dementia care in India. The study reports how the pair performed.

Catalog record

CREATORFaheem Arshad, Sarada Subramanian, Subasree Ramakrishnan, Suvarna Alladi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714681

Browse the full library · About the Tower of Babel